Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study.

CONCLUSION: Female breast cancer patients showed higher incidence of second primary malignancy, which was associated with poorer prognosis. Chemotherapy benefits should be weighed against the risks of second primary malignancy. PMID: 30888527 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30888527?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - March 18, 2019 Category: Cancer & Oncology Authors: Wei JL, Jiang YZ, Shao ZM Tags: Int J Clin Oncol Source Type: research